Conditions
Pancreatic Cancer
5 articles published between May 8, 2026 and September 24, 2026.
Covered in Tech & Medicine, Policy, Body and Science.
WHAT THE STUDY ACTUALLY SAYSA deep-learning model reads the pancreas on non-contrast CT taken for other reasons. It reached very high accuracy in large tests — none of them a prospective screening trial.
4 min read
EXPLAINERA, B, C, D and I are not school marks. They encode how strong the evidence is, whether to screen at all — and in the US, whether insurance has to pay for it.
4 min read
EXPLAINERThe disease is lethal largely because it is found late. That is also why guidelines recommend against screening the general public — the evidence says it would do more harm than good.
3 min read
EXPLAINERStage describes how far a cancer has spread at diagnosis. It is not the same as grade, it is set once, and it drives both prognosis and treatment more than almost any other number.
4 min read
THE DRUG DOCKETBizengri now covers NRG1-fusion cholangiocarcinoma, a mutation found in a fraction of a fraction of cases. The evidence is 19 patients, of whom about a third responded.
3 min read
This page indexes this newspaper’s reporting on Pancreatic Cancer. It is not a medical reference entry, and nothing here is medical advice. See our editorial standards.